SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CVAS-an interesting california-based biotech company here
CVAS 0.0004000.0%Oct 7 9:32 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (107)12/3/2002 8:39:21 PM
From: Miljenko Zuanic   of 126
 
Thanks WE.

This PIa/b trial was part of the IND for PII trial, swing from SC to i.v. bolus dosing. Appears that staff work as coronary anti-clot agent. I am not aware that they are again presenting old staff, EPCI data. Anyway, for comparison check DNA anti-TF-mAb (PRO38747).

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext